BDNF and metabolic syndrome: It has been observed that those patients with chronic schizophrenia on long-term treatment with olanzapine and who suffer metabolic syndrome have lower scores in both immediate and delayed memory, attention, and total score in the RBANS battery, as well as lower levels of BDNF (45).